Bolivia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Bolivia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 2.8% year on year. In 2019, the country was ranked number 127 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 126 Cases. Bolivia is overtaken by Iraq, which was ranked number 126 with 129 Cases and is followed by Sudan with 122 Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 126.00 |
| 2018 | 110.00 |
| 2017 | 58.00 |
| 2016 | 70.00 |
| 2015 | 79.00 |
How does Bolivia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 126 |
#126
Iraq
|
129 | 2019 | +2.4 % | -8.0 % | View data | |
| 127 |
#127
Bolivia
|
126 | 2019 | +14.6 % | +2.8 % | View data | |
| 133 |
#133
Malawi
|
104 | 2019 | -17.5 % | -0.4 % | View data | |